{name}
{subtitle}
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
city
~44 mi. (Norway, Maine, +825 more cities)
facility
Stephens Memorial Hospital
biomarker
AKT1 Mutation, +91 more biomarkers
condition
Breast Carcinoma, +3 more conditions
drug
adavosertib, +26 more drugs
drug type
immunotherapy, +1 more type
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
city
~44 mi. (Norway, Maine, +954 more cities)
facility
Stephens Memorial Hospital
drug
crizotinib, +4 more drugs
drug type
chemotherapy, +2 more types
Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC)
city
~44 mi. (Norway, Maine, +388 more cities)
facility
Stephens Memorial Hospital
drug
atezolizumab, +4 more drugs
drug type
chemotherapy, +2 more types
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
city
~44 mi. (Norway, Maine, +577 more cities)
facility
Stephens Memorial Hospital
Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel
city
~44 mi. (Norway, Maine, +444 more cities)
facility
Stephens Memorial Hospital
drug
abiraterone, +3 more drugs
drug type
chemotherapy, +1 more type
Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study
city
~46 mi. (Berlin, New Hampshire, +523 more cities)
facility
Central Vermont Medical Center/National Life Cancer Treatment
drug
cabozantinib, +2 more drugs
drug type
immunotherapy, +1 more type